Use of Ceftolozane/Tazobactam for the Treatment of Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Pneumonia in a Pediatric Patient with Combined Immunodeficiency (CID): A Case Report from a Tertiary Hospital in Saudi Arabia

Use of Ceftolozane/Tazobactam for the Treatment of Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Pneumonia in a Pediatric Patient with Combined Immunodeficiency (CID): A Case Report from a Tertiary Hospital in Saudi Arabia

Infections, with multidrug-resistant <i>Pseudomonas aeruginosa</i>, are a major concern in the pediatric intensive care unit, especially in immunocompromised patients. Some of these strains are resistant to all beta-lactams, including carbapenems, leaving very limited treatment options r...

Full description

Bibliographic Details
Main Authors: Ahmed Zikri, Kamal El Masri
Format: Article
Language:English
Published: MDPI AG 2019-05-01
Series:Antibiotics
Subjects:
ceftolozane/tazobactam
Pseudomonas
resistance
pneumonia
immunodeficiency
Online Access:https://www.mdpi.com/2079-6382/8/2/67

Similar Items

Similar Items